Furthermore, because natriuretic peptides are reflective of volume status, it can be difficult to use BNP as a marker to distinguish between patients with severe HFrEF and patients with non-cardiac origin volume overload, such as renal failure. This evidence concerns the gene NPPB and acute kidney injury.